EquiMed logo.
Horse Health Matters® Digest

Sign up to receive our monthly equine health digest!

FDA Evaluating Antiparasitic Drug Use

Newsdate: 
Sun, 13 Feb 2011 - 10:36 AM
Location: 
WASHINGTON, D.C.

The Food and Drug Administration (FDA) has announced that it is investigating the use of antiparasitic drugs in the United States and worldwide. A public meeting will be held on March 5-6, 2012, in Rockville, Maryland to allow comments and input.

Antiparasitic drug use and resistance in equines

Antiparasitic drug use and resistance in equines

FDA has announced it is investigating the use and effectiveness of antiparasitic drugs. New window.

The meeting entitled "Antiparasitic Drug Use and Resistance in Ruminants and Equines" is scheduled to discuss the current state of anthelmintic resistance in the United States and worldwide, tools for the evaluation of antiparasitic resistance, evaluation of the effectiveness of drugs against resistant parasites, and the scientific rationale for the use of combinations of antiparasitic drugs in ruminants and equines.

Interested persons may present data, information, or views, orally or in writing, on the topic of the discussion of the meeting. Written submissions may be made to the contact person on or before February 27, 2012.

Those desiring to make oral presentations should notify the contact person by February 20, 2012, and submit a brief statement of the general nature of information they wish to present and an indication of the approximate time requested to make their presentation. Time allotted for each presentation may be limited. Each speaker will be notified of their schedule prior to the meeting.

Registration is not required for this meeting; however, early arrival is recommended because seating may be limited. If you need special accommodations due to a disability, please contact Aleta Sindelar at least 7 days in advance.

Aleta.Sindelar@fda.hhs.gov

For more information visit the FDA website at

http://www.ofr.gov/(S(1nfpqzcpslwqlegwv33jmuta))/OFRUpload/OFRData/2012-03221_PI.pdf

Post new comment

The content of this field is kept private and will not be shown publicly.
  • HTML tags will be transformed to conform to HTML standards.

More information about formatting options

By submitting this form, you accept the Mollom privacy policy.
Drugs & Medications News

© Copyright 2009-2012, EquiMed, LLC
EquiMed® and Horse Health Matters® are registered trademarks of EquiMed, LLC
EquiMed does not provide medical advice, diagnosis or treatment.